Logo Rabies Vaccine BP

RABIES VACCINE BP® OVERVIEW

Rabies Vaccine BP is an inactivated vaccine indicated for prophylactic immunisation against rabies and treatment of patients following suspected rabies contact.

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Rabies Vaccine BP Prescribing information

View the Rabies Vaccine BP SmPC

Why help protect your patients with Rabies Vaccine BP?

Rabies is an acute viral infection causing inflammation of the spinal cord and the brain1 that leads to the deaths of tens of thousands of people worldwide.2 In developing countries, where it is most often transmitted by stray dogs, rabies is still considered a major public health concern.2

Transmitted through the saliva of an infected mammal, usually via a bite, scratch of lick3 The incubation period for the disease is usually 1-3 months but can be anything from a week to 1 year.2

Vaccination may be considered for all travellers who will be living or visiting endemic areas especially if:3

  • visiting areas where access to post-exposure treatment and medical care is limited
  • they are planning higher risk activities such as cycling and running
  • they are planning to stay for more than one month

 

Rabies Vaccine BP can be used to help provide pre-exposure prophylaxis and also as post-exposure treatment.

Logo Rabies Vaccine BP

Rabies vaccine ≥ 2.5 IU/ml (inactivated)

 

Presentation 1 ml prefilled diluent syringe + vial of lyophilised powder
Available in 1 vial
+ 1 syringe packs
Schedule

Pre-exposure prophylaxis:

3 doses at 0, 7 and 21 or 28 days Post-exposure prophylaxis:

- In persons known to have adequate prophylaxis two further boosters should be given, one on day 0 and one on day 3

- In persons with no, or possibly inadequate, prophylaxis the first injection of rabies vaccine (day 0) should be given as soon as possible after the suspected contact and followed by four further doses on days 3, 7, 14, and 30

Further doses

For those at regular and continuing risk, a single reinforcing dose of vaccine should be given at 1 year after the primary course has been completed. Further doses should be given at three to five-year intervals thereafter For travellers at intermittent risk of exposure, booster doses may be given in line with official recommendations

Age range

No lower or upper age limit listed

 

References:

  1. http://www.fitfortravel.nhs.uk/advice/disease-prevention-advice/rabies Accessed May 2018.
  2. WHO Rabies Fact sheet. http://www.who.int/en/news-room/fact-sheets/detail/rabies Accessed May 2018.
  3. National Travel Health Network and Centre (NaTHNaC). Travel Health Pro – Factsheet: Rabies. Available at: http://travelhealthpro.org.uk/factsheet/20/rabies (Accessed November 2018)

RABIES VACCINE BP SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Rabies Vaccine BP Prescribing information

View the Rabies Vaccine BP SmPC

Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

Date of preparation: November 2018 | SAGB.MIS.18.08.1323t